Dr Scott Soefje Says New Biosimilar Workflow Completely Simplified the System

Scott Soefje, PharmD, director of pharmacy cancer care at Mayo Clinic, explains how education can help with biosimilar adoption and how an updated biosimilar workflow has simplified the prior authorization process.

Related Keywords

Scott Soefje , ,Biosimilars ,Workflow ,Mayo Clinic ,Education ,Pharmacy ,